| |
|
|
|
CfPA-The Center for Professional Advancement, New Brunswick, NJ
March 14-17, 2016
Who Should Attend?
This broadly based course is intended for all scientists and technologists concerned with the development and processing of tablets, capsules and similar products, and with related drug regulatory affairs.
The material will be presented in such a way as to be of value to a varying level of expertise. This course will especially benefit those in:
• Quality Assurance
• Marketing
• Validation
• Purchasing
• R&D
• Regulatory Affairs
• Manufacturing/Production
• Engineering Support
Note: Persons seeking an in-depth treatment of only one or two of the major topics of this broadly based program may wish to consider alternative, more specialized courses offered by CfPA in this area of technology.
RAPS - Regulatory Affairs Professional Society
This course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's recertification of their Regulatory Affairs Certification (RAC) upon full completion. Course Description
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
| Dr. Cecil W. Propst; Research Fellow, SPI Pharma, Grand Haven |
Dr. Cecil W. Propst is a Research Fellow for SPI Pharma, a processor of a variety of specialty ingredients for the food, drug, cosmetic and related industries. He was Director of R&D (Grand Haven site) at SPI Pharma until semi retirement in 2015. He served as Director of Quality Assurance and Technical Services at Fleming and Company, and before that, President of Manufacturing Chemists. His duties included system design, product and process development and regulatory affairs. Previously, he served as cGMP Facilities Director for the University of Maryland at Baltimore, in connection with the University’s SPAC contract with the FDA.
Dr. Propst also served as Director of Technical Development for Stellar Manufacturing; Director of Quality Compliance for SmithKline Beecham; Director, Quality Assurance for Norcliff Thayer (a Revlon Company); and Group Leader/ Product Development and Manager/Quality Control for Lewis Howe Company. He also serves as a consultant in the area of product development and process investigations for the chemical, diagnostic, food, engineering and beverage industries.
Additional Faculty
Dr. Larry L. Augsburger, Professor, University of Maryland, School of Pharmacy
Mr. Charles Cunningham, Technical Director, Colorcon Ltd.
Mr. Dilip Parikh, President and CEO of DPharma Group
Dr. Martin Thomas, Director, Science and Technology, Quantachrome
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|
Formal sessions of the course are supplemented with informal discussion periods between lecturers and course participants and problem-solving sessions are held on both an open and private basis.